Novavax's COVID vaccine shows long-term efficacy in UK trial
(Reuters) - Novavax Inc said on Monday that an extended analysis of a late-stage study conducted in the United Kingdom showed that its COVID-19 vaccin...
Source: whbl.com
Carl Odonnell News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Carl Odonnell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Carl Odonnell Today - Breaking & Trending Today
Novavax's COVID vaccine shows long-term efficacy in UK trial
Novavax Inc said on Monday it would pursue full approval of its COVID-19 vaccine in the second half of this year and forecast total revenue of between $4 billion and $5 billion for 2022. ... | February 28, 2022
Source: marketscreener.com
U.S. delays decision on COVID vaccine for children under 5 by at least 2 months
(Reuters) - A U.S. decision on Pfizer and BioNTech's COVID-19 vaccine for children 6 months through 4 years of...
Source: 1470wmbd.com
Novavax underdelivers on COVID vaccine promises
By Carl O'Donnell, Francesco Guarascio and Neil Jerome Morales (Reuters) - Novavax Inc has delivered just a small fraction of the 2 billion COVID-19 shots it plans to send around the world in 2022 and has delayed first-quarter shipments in Europe and lower income countries such as the Philippines, public officials involved in their government's vaccine rollouts told Reuters. Novavax said it has completed delivery of only around 10 million vaccine doses so far, but is moving as quickly as possible to ship its contracted supplies for this quarter. Some shipments have been held up by regulatory p...
Source: swissinfo.ch
Biogen urges Medicare to reverse proposed limits on coverage of Alzheimer's drug
By Carl O'Donnell (Reuters) - Biogen Inc is urging Medicare to broadly reimburse its recently authorized Alzheimer's drug, in response to a proposal b...
Source: whbl.com